Jorge Eduardo Hernández-Del Río
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jorge Eduardo Hernández-Del Río has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Silvia Esmeralda Pérez-Topete
Reumatología, Unidad de Cardiología y Reumatología, Guadalajara, Jalisco, Mexico
7 shared publications- Tomás Miranda-Aquino
Departamento de Cardiología, Antiguo Hospital Civil de Guadalajara “Fray Antonio Alcalde”, Guadalajara 44280, Mexico
7 shared publications Verónica González-Díaz
Reumatología, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico
7 shared publicationsChristian González-Padilla
Cardiología. Hospital Civil de Guadalajara "Fray Antonio Alcalde", Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico
6 shared publicationsSergio Cerpa-Cruz
Reumatología, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico
5 shared publications- Christian Gonzalez-Padilla
Departamento de Cardiología, Antiguo Hospital Civil de Guadalajara “Fray Antonio Alcalde”, Guadalajara 44280, Mexico
4 shared publications
Latest Publications
- Open Access
- 26 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 214
In-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Mexican Tertiary University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases, and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Calibration was assessed with bootstrap calibration plots and the Hosmer–Lemeshow test. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9% in a young cohort (median 37 years) characterized by high hemodialysis prevalence (47.4%), substantial right-sided IE (46.4%), and Staphylococcus aureus predominance (32%) with no methicillin-resistant isolates. Vasopressor-requiring shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908), significantly outperforming RiskE (0.598) and ICE (0.632). The Bayesian WISCA identified multiple carbapenem-sparing and anti-MRSA–sparing regimens with adequate coverage (≥80%), particularly for community-acquired IE, supporting stewardship-oriented empirical selection. Coverage was consistently lower in healthcare-associated IE. Conclusions: A parsimonious three-variable model provided strong, locally valid mortality prediction in this hemodialysis-predominant, MRSA-free cohort, substantially outperforming European-derived scores. External validation in independent cohorts is required before clinical adoption. The Bayesian WISCA demonstrated that adequate empirical coverage is achievable without routine broad-spectrum agents, offering institution-specific guidance for stewardship-compatible regimen selection; multicenter validation is warranted.
- 26 April 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (2) , 214
Open AccessIn-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Mexican Tertiary University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases, and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Calibration was assessed with bootstrap calibration plots and the Hosmer–Lemeshow test. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9% in a young cohort (median 37 years) characterized by high hemodialysis prevalence (47.4%), substantial right-sided IE (46.4%), and Staphylococcus aureus predominance (32%) with no methicillin-resistant isolates. Vasopressor-requiring shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908), significantly outperforming RiskE (0.598) and ICE (0.632). The Bayesian WISCA identified multiple carbapenem-sparing and anti-MRSA–sparing regimens with adequate coverage (≥80%), particularly for community-acquired IE, supporting stewardship-oriented empirical selection. Coverage was consistently lower in healthcare-associated IE. Conclusions: A parsimonious three-variable model provided strong, locally valid mortality prediction in this hemodialysis-predominant, MRSA-free cohort, substantially outperforming European-derived scores. External validation in independent cohorts is required before clinical adoption. The Bayesian WISCA demonstrated that adequate empirical coverage is achievable without routine broad-spectrum agents, offering institution-specific guidance for stewardship-compatible regimen selection; multicenter validation is warranted.
- Open Access
- 27 February 2026
- Published by MDPI AG in Preprints.org
In-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Referral University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9%. Septic shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest independent predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908) and outperformed RiskE (AUC 0.598) and ICE (AUC 0.632). Bayesian WISCA ranked vancomycin + gentamicin and meropenem + gentamicin highest (both 87.0%); several β-lactam–based combinations provided comparably high coverage without requiring routine carbapenems. Coverage was consistently higher for community-acquired than healthcare-associated IE. Conclusions: A simple variable model provided strong, locally valid mortality prediction and substantially outperformed international scores in this hemodialysis-predominant cohort. Bayesian WISCA offers stable, institution-specific empirical coverage estimates that can support stewardship-oriented regimen selection; multicenter validation is warranted.
- 27 February 2026
- Published by MDPI AG in Preprints.org
Open AccessIn-Hospital Mortality Predictors and a Bayesian Weighted-Incidence Antibiogram in Infective Endocarditis: A Seven-Year Cohort Study from a Referral University Hospital
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9%. Septic shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest independent predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908) and outperformed RiskE (AUC 0.598) and ICE (AUC 0.632). Bayesian WISCA ranked vancomycin + gentamicin and meropenem + gentamicin highest (both 87.0%); several β-lactam–based combinations provided comparably high coverage without requiring routine carbapenems. Coverage was consistently higher for community-acquired than healthcare-associated IE. Conclusions: A simple variable model provided strong, locally valid mortality prediction and substantially outperformed international scores in this hemodialysis-predominant cohort. Bayesian WISCA offers stable, institution-specific empirical coverage estimates that can support stewardship-oriented regimen selection; multicenter validation is warranted.
- Open Access
Arrhythmias as Part of Long COVID Syndrome in Hospitalized Patients That Survived a Severe COVID-19 Infection and the Potential Protective Role of Metformin in These Patients
Background: Cardiac arrhythmias are a frequent complication of acute SARS-CoV-2 infection. However, their long-term prevalence and clinical determinants among patients with post-COVID-19 syndrome, especially those previously hospitalized, remain poorly defined. Objectives: To assess the prevalence and types of arrhythmias in long COVID patients following hospitalization and to identify associated clinical risk factors. Methods: In this cross-sectional study, 53 patients previously hospitalized with confirmed COVID-19 were evaluated ≥3 months post-infection. All participants underwent a standardized clinical assessment, 12-lead electrocardiography, and 24 h Holter monitoring. Logistic and Cox regression analyses were performed to identify predictors of arrhythmia. Results: Arrhythmias were identified in 41.5% (n = 22) of patients. Atrial fibrillation (32%) was the most frequent arrhythmia, followed by sinus bradycardia (27%) and sinus tachycardia (18%). Age (OR 1.06, 95% CI 1.01–1.10, p = 0.01) and length of hospital stay (OR 1.1, 95% CI 1.01–1.2, p = 0.04) were independently associated with arrhythmia. Biguanide (metformin) therapy was inversely associated with the occurrence of arrhythmia (Exp(B) = 0.017, p = 0.008). Dyspnea (82.4%) and palpitations (41.5%) were the most commonly reported symptoms. Conclusions: Arrhythmias are common in patients with long COVID following severe disease. Advanced age and prolonged hospitalization are significant risk factors, while biguanide use may offer a protective effect. These findings underscore the need for targeted cardiac surveillance in this population.
Open AccessArrhythmias as Part of Long COVID Syndrome in Hospitalized Patients That Survived a Severe COVID-19 Infection and the Potential Protective Role of Metformin in These Patients
Background: Cardiac arrhythmias are a frequent complication of acute SARS-CoV-2 infection. However, their long-term prevalence and clinical determinants among patients with post-COVID-19 syndrome, especially those previously hospitalized, remain poorly defined. Objectives: To assess the prevalence and types of arrhythmias in long COVID patients following hospitalization and to identify associated clinical risk factors. Methods: In this cross-sectional study, 53 patients previously hospitalized with confirmed COVID-19 were evaluated ≥3 months post-infection. All participants underwent a standardized clinical assessment, 12-lead electrocardiography, and 24 h Holter monitoring. Logistic and Cox regression analyses were performed to identify predictors of arrhythmia. Results: Arrhythmias were identified in 41.5% (n = 22) of patients. Atrial fibrillation (32%) was the most frequent arrhythmia, followed by sinus bradycardia (27%) and sinus tachycardia (18%). Age (OR 1.06, 95% CI 1.01–1.10, p = 0.01) and length of hospital stay (OR 1.1, 95% CI 1.01–1.2, p = 0.04) were independently associated with arrhythmia. Biguanide (metformin) therapy was inversely associated with the occurrence of arrhythmia (Exp(B) = 0.017, p = 0.008). Dyspnea (82.4%) and palpitations (41.5%) were the most commonly reported symptoms. Conclusions: Arrhythmias are common in patients with long COVID following severe disease. Advanced age and prolonged hospitalization are significant risk factors, while biguanide use may offer a protective effect. These findings underscore the need for targeted cardiac surveillance in this population.
- 25 September 2025
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 21 (8) , 250178
Erratum to Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis’
- 25 September 2025
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 21 (8) , 250178
Erratum to Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis’
- 21 April 2025
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 21 (3) , 501841
Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis
- 21 April 2025
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 21 (3) , 501841
Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis
- 13 March 2025
- Published by Elsevier in Reumatología Clínica
- Vol. 21 (3)
Acoplamiento ventriculoarterial derecho como marcador de daño miocárdico subclínico en artritis reumatoide
- 13 March 2025
- Published by Elsevier in Reumatología Clínica
- Vol. 21 (3)
Acoplamiento ventriculoarterial derecho como marcador de daño miocárdico subclínico en artritis reumatoide
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11737: Transhepatic Echocardiographic Approach Compared to the Subcostal Approach for Evaluation of the Inferior Vena Cava in Postoperative Patients With Cardiac Surgery
Introduction: In postoperative cardiac surgery patients due to the presence of mediastinal tubes, evaluation of the IVC is complicated with the subcostal view, so the transhepatic view could be an option for its evaluation in these patients. Methods: We obtained a validation group of non-surgical patients and later in a group of postoperative cardiac surgery patients with mediastinal tubes. Measurements of the IVC diameter in both views was obtained. Agreement between measurements diameters, the time it took to obtain the images, the degree of pain and the quality of the echocardiographic image were compared. The agreement of the variables was determined by the Pearson test. Results: A total of 43 patients were obtained from the validation group and 49 patients from the group of postsurgical patients. In the validation group, no significant difference was found in the maximum diameter in subcostal vs. transhepatic (15.6 (± 6.1) vs 16.0 (± 6.2); p = 0.9, r = 0.93), neither in the minimum diameter (11.2 (± 6.8) vs 11.5 (± 6.8); p = 0.7, r = 0.94), nor at the time of execution of the images (15 (11-23) vs 10 (7 -21); p = 0.09, r = 0.17, neither in pain. The transhepatic view had a good image quality (98 % vs 85 %; p = 0.007). In the group of postsurgical patients, no significant difference was found in the maximum diameter in subcostal vs. transhepatic (18.3 (± 5.2) vs. 18.1 (± 4.8); p = 0.8, r = 0.90), neither in the minimum diameter (14.5 (± 5.4) vs 14.3 (± 7.2); p = 0.9, r = 0.93), the time to acquire the image was superior to the subcostal view (57s (40-83) vs 18s (12-32); p = < 0.0001, r = 0.43); the subcostal view had an analogous visual scale of major pain (8 vs 0; p = < 0.0001), transhepatic view had a better good image quality (96 % vs 40 %; p = < 0.0001). Conclusions: In cardiac postoperative patients, it is possible to use the transhepatic view because it has an excellent agreement with the values of the subcostal window, with less time to obtain the images and with better image quality.
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11737: Transhepatic Echocardiographic Approach Compared to the Subcostal Approach for Evaluation of the Inferior Vena Cava in Postoperative Patients With Cardiac Surgery
Introduction: In postoperative cardiac surgery patients due to the presence of mediastinal tubes, evaluation of the IVC is complicated with the subcostal view, so the transhepatic view could be an option for its evaluation in these patients. Methods: We obtained a validation group of non-surgical patients and later in a group of postoperative cardiac surgery patients with mediastinal tubes. Measurements of the IVC diameter in both views was obtained. Agreement between measurements diameters, the time it took to obtain the images, the degree of pain and the quality of the echocardiographic image were compared. The agreement of the variables was determined by the Pearson test. Results: A total of 43 patients were obtained from the validation group and 49 patients from the group of postsurgical patients. In the validation group, no significant difference was found in the maximum diameter in subcostal vs. transhepatic (15.6 (± 6.1) vs 16.0 (± 6.2); p = 0.9, r = 0.93), neither in the minimum diameter (11.2 (± 6.8) vs 11.5 (± 6.8); p = 0.7, r = 0.94), nor at the time of execution of the images (15 (11-23) vs 10 (7 -21); p = 0.09, r = 0.17, neither in pain. The transhepatic view had a good image quality (98 % vs 85 %; p = 0.007). In the group of postsurgical patients, no significant difference was found in the maximum diameter in subcostal vs. transhepatic (18.3 (± 5.2) vs. 18.1 (± 4.8); p = 0.8, r = 0.90), neither in the minimum diameter (14.5 (± 5.4) vs 14.3 (± 7.2); p = 0.9, r = 0.93), the time to acquire the image was superior to the subcostal view (57s (40-83) vs 18s (12-32); p = < 0.0001, r = 0.43); the subcostal view had an analogous visual scale of major pain (8 vs 0; p = < 0.0001), transhepatic view had a better good image quality (96 % vs 40 %; p = < 0.0001). Conclusions: In cardiac postoperative patients, it is possible to use the transhepatic view because it has an excellent agreement with the values of the subcostal window, with less time to obtain the images and with better image quality.
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11441: Triplane Left Atrial Strain
The objective was to compare the percentage of myocardial deformation of the left atrium evaluated by monoplanar, biplanar and triplanar measurement. A total of 126 healthy patients were collected, of which 71 (56%) were male, the mean age of the population was 38 years (±16). Intraobserver and interobserver variability were adequate.The different values of the left atrium were compared. For the reservoir strain, only a significant difference was found between the apical 3-chamber and apical 2-chamber values reported; in pump strain there were no significant differences in values obtained; for the conduit strain, again the apical 3-chamber view was the lowest, finding a significant difference with the apical 4c, apical 2c and biplane views.The concordance of the reservoir strain of each apical view was independently related to the biplane and triplane views, finding that both apical 2c and 4c views had a good concordance with both biplane and triplane views, however, apical 3c view had a lower concordance. The same was found for pump strain and conduit strain, being Apical 2c and 4c views superior. Conclusion: The 3-chamber view has different left atrial strain values than the other apical views and the concordance of all other values of left atrium examination are similar, hence it is not further significant to perform a biplane or triplane examination.
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11441: Triplane Left Atrial Strain
The objective was to compare the percentage of myocardial deformation of the left atrium evaluated by monoplanar, biplanar and triplanar measurement. A total of 126 healthy patients were collected, of which 71 (56%) were male, the mean age of the population was 38 years (±16). Intraobserver and interobserver variability were adequate.The different values of the left atrium were compared. For the reservoir strain, only a significant difference was found between the apical 3-chamber and apical 2-chamber values reported; in pump strain there were no significant differences in values obtained; for the conduit strain, again the apical 3-chamber view was the lowest, finding a significant difference with the apical 4c, apical 2c and biplane views.The concordance of the reservoir strain of each apical view was independently related to the biplane and triplane views, finding that both apical 2c and 4c views had a good concordance with both biplane and triplane views, however, apical 3c view had a lower concordance. The same was found for pump strain and conduit strain, being Apical 2c and 4c views superior. Conclusion: The 3-chamber view has different left atrial strain values than the other apical views and the concordance of all other values of left atrium examination are similar, hence it is not further significant to perform a biplane or triplane examination.
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11327: De Novo Heart Failure in a Young Adult: A Case of Severe Aortic Regurgitation Secondary to an Aortic Root Aneurysm in a Patient With Marfan's Syndrome
A 24-year-old male, with no past medical history, presented to the ER with a 15-day history of insidious abdominal pain and distention, associated with progressive dyspnea on exertion and bilateral lower extremity pitting edema. In the previous 48 hours before his hospital admission, patient began presenting orthopnea and paroxysmal nocturnal dyspnea.On presentation patient was normotensive and tachycardic, with low oxygen saturation on pulse oximetry. On auscultation a loud early diastolic decrescendo murmur was heard at the parasternal border, with and audible S3 gallop. Characteristic Marfanoid habitus was observed. Patient underwent TTE were there was a notable aortic root dilation, mainly at the level of the sinuses of Valsalva, which had a diameter of 85 mm and 62 mm at the sinotubular junction. Ascending and descending aorta had a normal diameter. An eccentric jet of severe aortic regurgitation was also noted, which collided with the anterior mitral valve leaflet causing an Austin Flint phenomenon. Left ventricular ejection fraction was estimated at 24%, severe dilation was noted on all chambers. There were no echocardiographic signs of aortic dissection. Patient underwent genetic testing and ophthalmic evaluation, confirming the diagnosis of Marfan’s syndrome. A contrast enhanced CT angiogram confirmed the presence of severe aortic root dilation without dissection. Patient underwent Bentall procedure and began treatment for HFrEF at discharge. Marfan Syndrome is an autosomal dominant connective tissue disorder, due to mutations mostly in the FBN1 gene. Most cardiovascular symptoms are related to dilation of the aortic root and subsequent aortic regurgitation due to aortic annulus dilation. In patients with Marfan’s syndrome, all aortic root aneurysms ≥5.0 mm should undergo surgical repair regardless of symptoms.
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11327: De Novo Heart Failure in a Young Adult: A Case of Severe Aortic Regurgitation Secondary to an Aortic Root Aneurysm in a Patient With Marfan's Syndrome
A 24-year-old male, with no past medical history, presented to the ER with a 15-day history of insidious abdominal pain and distention, associated with progressive dyspnea on exertion and bilateral lower extremity pitting edema. In the previous 48 hours before his hospital admission, patient began presenting orthopnea and paroxysmal nocturnal dyspnea.On presentation patient was normotensive and tachycardic, with low oxygen saturation on pulse oximetry. On auscultation a loud early diastolic decrescendo murmur was heard at the parasternal border, with and audible S3 gallop. Characteristic Marfanoid habitus was observed. Patient underwent TTE were there was a notable aortic root dilation, mainly at the level of the sinuses of Valsalva, which had a diameter of 85 mm and 62 mm at the sinotubular junction. Ascending and descending aorta had a normal diameter. An eccentric jet of severe aortic regurgitation was also noted, which collided with the anterior mitral valve leaflet causing an Austin Flint phenomenon. Left ventricular ejection fraction was estimated at 24%, severe dilation was noted on all chambers. There were no echocardiographic signs of aortic dissection. Patient underwent genetic testing and ophthalmic evaluation, confirming the diagnosis of Marfan’s syndrome. A contrast enhanced CT angiogram confirmed the presence of severe aortic root dilation without dissection. Patient underwent Bentall procedure and began treatment for HFrEF at discharge. Marfan Syndrome is an autosomal dominant connective tissue disorder, due to mutations mostly in the FBN1 gene. Most cardiovascular symptoms are related to dilation of the aortic root and subsequent aortic regurgitation due to aortic annulus dilation. In patients with Marfan’s syndrome, all aortic root aneurysms ≥5.0 mm should undergo surgical repair regardless of symptoms.
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11379: Libman-Sacks Endocarditis Mimicking Intracardiac Tumor in a Patient With Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome
A 43-year-old woman, with history of SLE for 12 years and secondary APS for 10 years. Hospitalized in 2016 by pulmonary embolism, finding on that occasion the presence of intracardiac mass in the right atrial, at that time, she was pregnant and had full anticoagulation with LMWH until the end of the pregnancy. Since then, in treatment with azathioprine, hydroxychloroquine and acenocoumarin irregularly. She presented to the ER with a 21-day history of abdominal distention and diffuse pain, dyspnea at rest, and bilateral lower extremity pitting edema. On presentation patient was normotensive and tachycardic, in anasarca and with a loud holosystolic murmur at the parasternal border, in fifth intercostal space. Was admitted for acute heart failure. In TTE, the persistence of the right atrial mass dependent on interatrial septum with greater growth than the previous one was observed. The tumor protruded within the entrance tract of the right ventricle during diastole and during systole a doble jet of severe tricuspid regurgitation is observed. The tricuspid valve was thickened. A contrasted enhanced cardiac magnetic resonance confirmed the presence of the tumor described above without contrast uptake. The patient underwent mass excision surgery with preoperative diagnosis of atrial myxoma. Microscopic examination of the excised material revealed dispersed lymphohistiocytic infiltrate and thrombi without evidence of microorganisms, compatible with Limban-Sacks endocarditis. Because of the size and location of the lesion, Libman-Sacks endocarditis was considered highly unlikely. Only few cases of a vegetation simulating an intracardiac mass have been reported and in these patients analysis of serologic markers showed that lupus anticoagulant was positive, anticardiolipin antibodies IgM-G and antiphospholipid antibody were high.
- 8 November 2022
- Published by Wolters Kluwer Health in Circulation
- Vol. 146 (Suppl_1)
Abstract 11379: Libman-Sacks Endocarditis Mimicking Intracardiac Tumor in a Patient With Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome
A 43-year-old woman, with history of SLE for 12 years and secondary APS for 10 years. Hospitalized in 2016 by pulmonary embolism, finding on that occasion the presence of intracardiac mass in the right atrial, at that time, she was pregnant and had full anticoagulation with LMWH until the end of the pregnancy. Since then, in treatment with azathioprine, hydroxychloroquine and acenocoumarin irregularly. She presented to the ER with a 21-day history of abdominal distention and diffuse pain, dyspnea at rest, and bilateral lower extremity pitting edema. On presentation patient was normotensive and tachycardic, in anasarca and with a loud holosystolic murmur at the parasternal border, in fifth intercostal space. Was admitted for acute heart failure. In TTE, the persistence of the right atrial mass dependent on interatrial septum with greater growth than the previous one was observed. The tumor protruded within the entrance tract of the right ventricle during diastole and during systole a doble jet of severe tricuspid regurgitation is observed. The tricuspid valve was thickened. A contrasted enhanced cardiac magnetic resonance confirmed the presence of the tumor described above without contrast uptake. The patient underwent mass excision surgery with preoperative diagnosis of atrial myxoma. Microscopic examination of the excised material revealed dispersed lymphohistiocytic infiltrate and thrombi without evidence of microorganisms, compatible with Limban-Sacks endocarditis. Because of the size and location of the lesion, Libman-Sacks endocarditis was considered highly unlikely. Only few cases of a vegetation simulating an intracardiac mass have been reported and in these patients analysis of serologic markers showed that lupus anticoagulant was positive, anticardiolipin antibodies IgM-G and antiphospholipid antibody were high.